Francesco Panzuto | Ricerc@Sapienza

Publications

Title	Published on	Year
Nutritional aspects in neuroendocrine neoplasms. bridging the gap between dietary interventions and cancer care strategies: a scoping review	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION	2024
Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM)	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION	2024
Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogs	JOURNAL OF NEUROENDOCRINOLOGY	2024
Exploring carcinoid syndrome in neuroendocrine tumors: insights from a multidisciplinary narrative review	CANCERS	2024
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size. a retrospective, Europe-wide, pooled cohort study	THE LANCET ONCOLOGY	2023
Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists	CANCER TREATMENT REVIEWS	2023
Management of functional pancreatic neuroendocrine neoplasms	CURRENT TREATMENT OPTIONS IN ONCOLOGY	2023
European Neuroendocrine Tumor Society (ENETS) 2023 Guidance Paper for Gastroduodenal NET G1‐G3	JOURNAL OF NEUROENDOCRINOLOGY	2023
Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia	ENDOCRINE	2023
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastro entero pancreatic neuroendocrine tumors: alternatives to RECIST	JOURNAL OF NEUROENDOCRINOLOGY	2023
Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma	DIGESTIVE AND LIVER DISEASE	2023
When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors?	JOURNAL OF CLINICAL MEDICINE	2023
The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors	EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY	2023
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial	BMC CANCER	2023
Outcomes of a 3-year prospective surveillance in individuals at high-risk for pancreatic cancer	THE AMERICAN JOURNAL OF GASTROENTEROLOGY	2023
Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker?	ENDOCRINE	2023
Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group	ADVANCES IN THERAPY	2023
Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma	JOURNAL OF GASTROINTESTINAL ONCOLOGY	2023
Necrolytic Migratory Erythema Impact on Prognosis and Diagnosis of Glucagonoma: A Case Report	HSOA JOURNAL OF CLINICAL STUDIES & MEDICAL CASE REPORTS	2023
Role of [18F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors	ENDOCRINE	2022